Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin C De Braganca

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Neurology and Neuroscience Reports|May 8, 2008
Neurotoxicity of chemotherapeutic and biologic agents in children with cancerKevin C De Braganca, Roger J Packer
Current Treatment Options in Neurology|August 28, 2013
Treatment Options for Medulloblastoma and CNS Primitive Neuroectodermal Tumor (PNET)Kevin C De Braganca, Roger J Packer
Journal of Child Neurology|September 4, 2015
MedulloblastomaNathan E Millard, Kevin C De Braganca
Pediatric Blood & Cancer|December 16, 2014
Extraneural metastases of medulloblastoma: desmoplastic variants may have prolonged survivalRobert J Young, Yasmin Khakoo, Stephen Yhu, et al.
Cancers|March 14, 2026
Outpatient Versus Inpatient Administration of Ciltacabtagene Autoleucel in Multiple Myeloma: A Systematic Review of Clinical, Economic, and Humanistic OutcomesTara Gregory, Kevin C De Braganca, Victoria Alegria, et al.
Cancers|December 23, 2023
The Impact of Outpatient versus Inpatient Administration of CAR-T Therapies on Clinical, Economic, and Humanistic Outcomes in Patients with Hematological Cancer: A Systematic Literature ReviewDoris K Hansen, Yi-Hsuan Liu, Sandip Ranjan, et al.
Molecular Genetics and Metabolism|August 5, 2008
The molecular basis of pyruvate carboxylase deficiency: mosaicism correlates with prolonged survivalDong Wang, Hong Yang, Kevin C De Braganca, et al.
Journal of Neuro-Oncology|June 30, 2017
Reduced-volume radiotherapy for patients with localized intracranial nongerminoma germ cell tumorsBrian De, Oren Cahlon, Ira J Dunkel, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 12, 2026
FORTRESS-CART: Focused Observation and Risk Testing for Robust Evaluation of Safety in Chimeric Antigen Receptor T-Cell Therapy (CAR-T): Real-World Predictors of Second Primary Malignancies (SPMs) Among Patients Treated With CAR-TRafael Fonseca, Surbhi Sidana, Kevin C De Braganca, et al.
Journal of Neuro-Oncology|March 8, 2018
Patterns of relapse for children with localized intracranial ependymomaBrian De, Yasmin Khakoo, Mark M Souweidane, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Neurology and Neuroscience Reports|May 8, 2008
Neurotoxicity of chemotherapeutic and biologic agents in children with cancerKevin C De Braganca, Roger J Packer
Current Treatment Options in Neurology|August 28, 2013
Treatment Options for Medulloblastoma and CNS Primitive Neuroectodermal Tumor (PNET)Kevin C De Braganca, Roger J Packer
Journal of Child Neurology|September 4, 2015
MedulloblastomaNathan E Millard, Kevin C De Braganca
Pediatric Blood & Cancer|December 16, 2014
Extraneural metastases of medulloblastoma: desmoplastic variants may have prolonged survivalRobert J Young, Yasmin Khakoo, Stephen Yhu, et al.
Cancers|March 14, 2026
Outpatient Versus Inpatient Administration of Ciltacabtagene Autoleucel in Multiple Myeloma: A Systematic Review of Clinical, Economic, and Humanistic OutcomesTara Gregory, Kevin C De Braganca, Victoria Alegria, et al.
Cancers|December 23, 2023
The Impact of Outpatient versus Inpatient Administration of CAR-T Therapies on Clinical, Economic, and Humanistic Outcomes in Patients with Hematological Cancer: A Systematic Literature ReviewDoris K Hansen, Yi-Hsuan Liu, Sandip Ranjan, et al.
Molecular Genetics and Metabolism|August 5, 2008
The molecular basis of pyruvate carboxylase deficiency: mosaicism correlates with prolonged survivalDong Wang, Hong Yang, Kevin C De Braganca, et al.
Journal of Neuro-Oncology|June 30, 2017
Reduced-volume radiotherapy for patients with localized intracranial nongerminoma germ cell tumorsBrian De, Oren Cahlon, Ira J Dunkel, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 12, 2026
FORTRESS-CART: Focused Observation and Risk Testing for Robust Evaluation of Safety in Chimeric Antigen Receptor T-Cell Therapy (CAR-T): Real-World Predictors of Second Primary Malignancies (SPMs) Among Patients Treated With CAR-TRafael Fonseca, Surbhi Sidana, Kevin C De Braganca, et al.
Journal of Neuro-Oncology|March 8, 2018
Patterns of relapse for children with localized intracranial ependymomaBrian De, Yasmin Khakoo, Mark M Souweidane, et al.
Pageof 3